Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney

Biochemical and Biophysical Research Communications

Volumn 469, Issue 1, 2016, Pages 108-113

  Cai, Mengyin ^a,b   Bompada, Pradeep ^a   Atac, David ^a   Laakso, Markku ^c   Groop, Leif ^a,d   De Marinis, Yang ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Diabetic kidney disease; Histone deacetylase (HDAC); Histone methyltransferase (HMT); Histone modification; Hyperglycemia; Osteopontin (OPN)

Indexed keywords

GLUCOSE; HISTONE H3; HISTONE H3K27ME3; HISTONE H3K4ME1; HISTONE H3K4ME3; HISTONE H3K9AC; MESSENGER RNA; OSTEOPONTIN; SULFONYLUREA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; E1506K GENE; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME REGULATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE MUTATION; GLUCOSE BLOOD LEVEL; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VIVO STUDY; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; KIDNEY; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; GLUCOSE; HISTONE CODE; KIDNEY; MICE; OSTEOPONTIN; PROMOTER REGIONS, GENETIC;

EID: 84950280045     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.079     Document Type: Article

References (25)

1. I.B. Hirsch, and M. Brownlee Beyond hemoglobin A1c-need for additional markers of risk for diabetic microvascular complications JAMA 303 2010 2291 2292
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The diabetes control and complications trial research group N. Engl. J. Med. 329 1993 977 986
3. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 2008 1577 1589
4. P. King, I. Peacock, and R. Donnelly The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes Br. J. Clin. Pharmacol. 48 1999 643 648
5. K. Susztak, E. Bottinger, A. Novetsky, D. Liang, Y. Zhu, E. Ciccone, D. Wu, S. Dunn, P. McCue, and K. Sharma Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease Diabetes 53 2004 784 794
6. N. Endlich, M. Sunohara, W. Nietfeld, E.W. Wolski, D. Schiwek, B. Kranzlin, N. Gretz, W. Kriz, H. Eickhoff, and K. Endlich Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 16 2002 1850 1852
7. C.M. Giachelli Vascular calcification: in vitro evidence for the role of inorganic phosphate J. Am. Soc. Nephrol.: JASN 14 2003 S300 S304
8. C.M. Giachelli, L. Liaw, C.E. Murry, S.M. Schwartz, and M. Almeida Osteopontin expression in cardiovascular diseases Ann. N. Y. Acad. Sci. 760 1995 109 126
9. C.P. Sodhi, D. Batlle, and A. Sahai Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK Kidney Int. 58 2000 691 700
10. J.R. Asplin, D. Arsenault, J.H. Parks, F.L. Coe, and J.R. Hoyer Contribution of human uropontin to inhibition of calcium oxalate crystallization Kidney Int. 53 1998 194 199
11. E.M. Worcester, and A.M. Beshensky Osteopontin inhibits nucleation of calcium oxalate crystals Ann. N. Y. Acad. Sci. 760 1995 375 377
12. T. Yamate, K. Kohri, T. Umekawa, E. Konya, Y. Ishikawa, M. Iguchi, and T. Kurita Interaction between osteopontin on madin darby canine kidney cell membrane and calcium oxalate crystal Urol. Int. 62 1999 81 86
13. G.F. Weber, S. Ashkar, M.J. Glimcher, and H. Cantor Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science 271 1996 509 512
14. S. Yamamoto, K. Nasu, T. Ishida, M. Setoguchi, Y. Higuchi, N. Hijiya, and S. Akizuki Effect of recombinant osteopontin on adhesion and migration of P388D1 cells Ann. N. Y. Acad. Sci. 760 1995 378 380
15. C.P. Sodhi, S.A. Phadke, D. Batlle, and A. Sahai Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin Am. J. Physiol. Ren. Physiol. 280 2001 F667 F674
16. J. Sun, Y. Xu, H. Deng, S. Sun, Z. Dai, and Y. Sun Involvement of osteopontin upregulation on mesangial cells growth and collagen synthesis induced by intermittent high glucose J. Cell. Biochem. 109 2010 1210 1221
17. S.B. Nicholas, J. Liu, J. Kim, Y. Ren, A.R. Collins, L. Nguyen, and W.A. Hsueh Critical role for osteopontin in diabetic nephropathy Kidney Int. 77 2010 588 600
18. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, R.G. Roeder, M.E. Cooper, and M. Brownlee Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J. Exp. Med. 205 2008 2409 2417
19. H. Huopio, T. Otonkoski, I. Vauhkonen, F. Reimann, F.M. Ashcroft, and M. Laakso A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1 Lancet 361 2003 301 307
20. K. Shimomura, M. Tusa, M. Iberl, M.F. Brereton, S. Kaizik, P. Proks, C. Lahmann, N. Yaluri, S. Modi, H. Huopio, J. Ustinov, T. Otonkoski, M. Laakso, and F.M. Ashcroft A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1 Diabetes 62 2013 3797 3806
21. Y. Dou, T.A. Milne, A.J. Tackett, E.R. Smith, A. Fukuda, J. Wysocka, C.D. Allis, B.T. Chait, J.L. Hess, and R.G. Roeder Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF Cell 121 2005 873 885
22. T.J. Hsieh, R. Chen, S.L. Zhang, F. Liu, M.L. Brezniceanu, C.I. Whiteside, I.G. Fantus, J.R. Ingelfinger, P. Hamet, and J.S. Chan Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling Kidney Int. 69 2006 1005 1015
23. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
24. G.J. Narlikar, H.Y. Fan, and R.E. Kingston Cooperation between complexes that regulate chromatin structure and transcription Cell 108 2002 475 487
25. R. Komers, D. Mar, O. Denisenko, B. Xu, T.T. Oyama, and K. Bomsztyk Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes Lab. Invest 93 2013 543 552